Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.1.1 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising trend of pet adoption
3.2.1.2 Technological innovation in treatments of arthritis for companion animals
3.2.1.3 Increasing prevalence of arthritis in aging pets
3.2.2 Industry pitfalls & challenges
3.2.2.1 High costs associated with advanced diagnostics, medications, and specialized treatments
3.2.2.2 Limited research and development
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Treatment Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Medication
5.2.1 NSAIDs
5.2.2 Monoclonal antibodies
5.2.3 Other medications
5.3 Food supplement
5.4 Surgery
5.5 Other treatment types
Chapter 6 Market Estimates and Forecast, By Disease Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Osteoarthritis
6.3 Rheumatoid arthritis
6.4 Other arthritis types
Chapter 7 Market Estimates and Forecast, By Animal Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Dogs
7.3 Cats
7.4 Other animals
Chapter 8 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Veterinary hospitals
8.3 Veterinary clinics
8.4 Veterinary rehabilitation centers
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 American Regent, Inc.
10.2 Bayer AG (Bayer Animal Health)
10.3 Boehringer Ingelheim International GmbH
10.4 CEVA Santé Animale
10.5 Dechra Pharmaceuticals plc
10.6 Elanco
10.7 Eltech K-Laser s.r.l.
10.8 Medivet
10.9 Norbrook laboratories
10.10 Nutramax Laboratories Veterinary Sciences, Inc
10.11 Vetoquinol SA
10.12 Vibrac
10.13 Zoetis, Inc.
